Progyny Inc (PGNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2018 | 06-2018 | 12-2017 | |
| Cash Flows From Operating Activities | |||
| Net Income | 2,186 | 3,322 | -12,452 |
| Depreciation Amortization | 1,470 | 996 | 1,559 |
| Income taxes - deferred | -1,230 | -835 | N/A |
| Accounts receivable | -15,340 | -13,021 | N/A |
| Accounts payable and accrued liabilities | 7,892 | 8,105 | N/A |
| Other Working Capital | -3,253 | -1,772 | -1,425 |
| Other Operating Activity | 6,451 | 1,929 | 2,844 |
| Operating Cash Flow | $-1,824 | $-1,276 | $-9,474 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -401 | -365 | -612 |
| Other Investing Activity | 2,428 | 2,427 | 0 |
| Investing Cash Flow | $2,027 | $2,062 | $-612 |
| Cash Flows From Financing Activities | |||
| Debt Issued | 35,003 | 6,659 | N/A |
| Debt Repayment | -36,066 | -9,291 | N/A |
| Common Stock Issued | 46 | 8 | N/A |
| Common Stock Repurchased | -1,205 | N/A | N/A |
| Other Financing Activity | -2,500 | -2,500 | 11,766 |
| Financing Cash Flow | $-4,722 | $-5,124 | $11,766 |
| Beginning Cash Position | 4,691 | 4,691 | 3,011 |
| End Cash Position | 172 | 353 | 4,691 |
| Net Cash Flow | $-4,519 | $-4,338 | $1,680 |
| Free Cash Flow | |||
| Operating Cash Flow | -1,824 | -1,276 | -9,474 |
| Capital Expenditure | -401 | -365 | N/A |
| Free Cash Flow | -2,225 | -1,641 | -9,474 |